Bosnian drug maker Bosnalijek to add 60 new products by 2024 - report

The company has introduced 120 new products over the past five years and has invested 50 million marka ($28.5 million/25.6 millio euro) in 2019 alone, business news portal eKapija.com reported. 

Bosnalijek currently has more than 240 products in its portfolio, including drugs, nutritional supplements and special purpose cosmetics.

The company has increased its workforce by 300 employees to 900 in the last five years, eKapija.com reported.

In October 2016, the government of Bosnia's Federation entity sold its 19.3% stake in Bosnalijek for 23.4 million marka to Malta-based financial services provider KBC Euro Credit Capital. Luxembourg-based Haden SA is the drug maker's largest shareholder with a stake of 25.9%, Sarajevo Stock Exchange data showed. 

(1 euro = 195583 marka)